Hubei Yuancheng Saichuang Technology Co.,Ltd

You are here: HomeProductsGonadorelin

Contact us

  • Company Name: Hubei Yuancheng Saichuang Technology Co.,Ltd
  • Country/region: China
  • Contact Person: Ms.killy lee
  • Tel: 86-027-50756254
  • Email:

Gonadorelin

    Detailed Description

    Gonadorelin
    Model NO.:Gonadorelin CAS: 33515-09-2
    CAS:77591-33-4
    Mf:C212h350n56o78s
    MW:4963.5
    Assay:99%
    Gonadorelin Peptide Origin:China
    Character:White Powder
    Shipment:Hkems, EMS, FedEx, TNT, DHL, UPS, Aramex
    Payment:Western Union, Money Gram, T/T, Bitcoin
    Packing Details:According to The Customer Request
    Effect:Bone Growth
    Export Markets:Global
    Uses
    Gonadorelin is used by women who are missing menstrual periods due to low levels of gonadotropin-releasing hormone (GnRH). It may be used as part of female infertility treatment. This medication provides GnRH that the body needs for the growth and release of mature eggs from the ovaries (ovulation).

    How does it work?
    Gonadorelin is a hormone that is produced naturally by the hypothalamus in the brain. It is also known as gonadotrophin-releasing hormone or GnRH.
    Gonadorelin stimulates the pituitary gland in the brain to release the sex hormones luteinising hormone (LH) and follicle stimulating hormone (FSH). In women, FSH stimulates the production of oestrogen and the development of eggs in the ovaries. LH stimulates the ovaries to release an egg (ovulation). In men, LH stimulates the testicles to produce the hormone testosterone and FSH stimulates the testicles to produce sperm.
    Gonadorelin is given by injection to check whether the pituitary gland is producing LH and FSH in the correct levels. This can help in the diagnosis of various hormonal disorders, including infertility, delayed puberty and hypogonadism.

    How is it given?
    The gonadorelin is given as a single injection either under the skin or into a vein.
    Blood samples to measure the levels of LH and FSH in the blood are usually taken 15 minutes before the gonadorelin injection, immediately before the injection and then at 15, 30, 45, 60 and 120 minutes after the injection.